← brief for 2026-08-19 · Slowing decline

Association of angiotensin receptor-neprilysin inhibitor therapy with changes in eGFR slope and home blood pressure in patients with chronic kidney disease.

Article B Peer reviewed Small trial

Key takeaways

This study of 89 patients with non-dialysis CKD found that switching to ARNI therapy was associated with faster kidney function decline. The study lasted 12 months.

Who did this work

Namikawa A · Shibuya Y · Yoshino D · Sato D · Furuto Y

Source

Article · PubMed, CKD progression and prevention · 2026 Aug 19
https://pubmed.ncbi.nlm.nih.gov/42616269/